Cite
HARVARD Citation
Ma, F. et al. (n.d.). 1131PDPreliminary results of phase I/II study of SENL-B19 chimeric antigen receptor T cell therapy in pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r-ALL). Annals of oncology. p. . [Online].